ArticleScientific reports2025
Non-prescribed drug use and its associated factors among pregnant women in Southwest Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-prescribed drug utilization is the act of using medication to treat self-diagnosed problems without consulting a healthcare provider. Pregnant women are among the most vulnerable population groups for self-medication to treat pregnancy-related problems. The use of non-prescribed drugs, however, has numerous detrimental effects on both the growing fetus and the mother. Besides, community-based information regarding the pattern of non-prescribed drug use is limited in Ethiopia. Hence, this study aims to investigate non-prescribed drug use and its associated factors among pregnant women in Jimma town, southwest Ethiopia, in 2023. A community-based cross-sectional study was conducted among 358 pregnant mothers in the peri-urban kebeles of Jimma town, southwest Ethiopia. A systematic random sampling technique (every K = 3 households) was used to select the final study participants. Data were collected using an interviewer-administered structured questionnaire, entered into EpiData version 7.2.2 software, and exported to SPSS version 25 for further analysis. Both bivariable and multivariable logistic regression models were fitted to identify the factors influencing non-prescribed drug utilization status. The level of significance of the association was determined at a P-value < 0.05 with a 95% CI. A total of 358 (99.4%) pregnant women participated in the study. The mean age of the participants was 25.06 years (Standard Deviation ± 4.25). Overall, the prevalence of non-prescribed drug use among pregnant women was 37.7% (95% CI: 32.8-41.7%). The most common reasons for using non-prescribed drugs were the easy availability of these drugs in pharmacies and drug stores, followed by their relatively low cost. Enrollment in health insurance (AOR = 0.21, 95% CI: 0.03-0.76), being primigravida (AOR = 3.05, 95% CI: 1.03-5.08), and experiencing pregnancy-related complications (AOR = 2.34, 95% CI: 1.99-2.76) were found to be significant factors influencing the utilization of non-prescribed drugs among pregnant mothers. In the current study, non-prescribed drug use among pregnant mothers was high. Health insurance enrollment status, gravidity, and the presence of any pregnancy-related complications were identified as significant predictors of non-prescribed drug use among pregnant mothers. Hence, stakeholders should invest their efforts in increasing community enrollment in health insurance programs and place special emphasis on high-risk groups prone to non-prescribed drug use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.